SMTL ID : 8h6p.1

Complex structure of CDK2/Cyclin E1 and a potent, selective macrocyclic inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.44 Å

Oligo State

hetero-1-1-mer

Ligands

1 x WZU: (7S,10R)-11-oxa-2,4,5,13,17,23-hexaazatetracyclo[17.3.1.1~3,6~.1~7,10~]pentacosa-1(23),3(25),5,19,21-pentaene-12,18-dione(Non-covalent)

WZU.1: 17 residues within 4Å: Chain A: I.11, Y.16, V.19, A.32, K.34, V.65, F.81, E.82, F.83, L.84, H.85, D.87, Q.132, N.133, L.135, A.145, D.146 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.11, A:V.19, A:V.65, A:F.81, A:F.81, A:F.81, A:F.81, A:L.135 Hydrogen bonds: A:L.84, A:L.84, A:D.87, A:D.146 Water bridges: A:N.133, A:D.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yu, Y. et al., Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design. Acs Med.Chem.Lett. (2023)

Release Date

2023-02-22

Peptides

Cyclin-dependent kinase 2: A
G1/S-specific cyclin-E1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 2

G1/S-specific cyclin-E1

Related Entries With Identical Sequence